Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome

Trimethylamine-N-oxide (TMAO), a derivative from the gut microbiota metabolite trimethylamine (TMA), has been identified to be an independent risk factor for promoting atherosclerosis. Evidences suggest that berberine (BBR) could be used to treat obesity, diabetes and atherosclerosis, however, its m...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xingxing, Su, Chunyan, Jiang, Zhibo, Yang, Yuxin, Zhang, Yue, Yang, Mengxia, Zhang, Xiumin, Du, Yu, Zhang, Jin, Wang, Li, Jiang, Jiandong, Hong, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052457/
https://www.ncbi.nlm.nih.gov/pubmed/33863898
http://dx.doi.org/10.1038/s41522-021-00205-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052457/
https://www.ncbi.nlm.nih.gov/pubmed/33863898
http://dx.doi.org/10.1038/s41522-021-00205-8

Ejemplares similares